skip to content

Department of Pathology

 
Read more at: Can We Predict Who Will Respond to COVID-19 Vaccines After an Organ Transplant?

Can We Predict Who Will Respond to COVID-19 Vaccines After an Organ Transplant?

3 July 2025

Spoiler: It’s complicated—but we're getting closer. A new study published in NPJ Vaccines by the Liston-Dooley Group took a deep dive into how solid organ transplant (SOT) recipients respond to COVID-19 mRNA vaccines—and what their immune systems might be telling us before they even get the shot. Why this matters: People...


Read more at: Unmasking HPV: How Gene Regulation Shapes the Battle Between Virus and Host

Unmasking HPV: How Gene Regulation Shapes the Battle Between Virus and Host

2 July 2025

Cervical cancer is a global health threat, and at the heart of its origin lies a microscopic agent: high-risk human papillomaviruses (HR-HPVs). But how do these viruses hijack our cells, and what causes their gene expression to spiral into cancer-causing chaos? Let’s explore the molecular tug-of-war between virus and host...


Read more at: P21 Activated Kinases: The Proteins That Control Cell Shape Without Lifting a Finger 

P21 Activated Kinases: The Proteins That Control Cell Shape Without Lifting a Finger 

30 June 2025

A recent study published by the Koronakis Lab has revealed an unexpected finding. We usually think of proteins as little machines that need to be “switched on” to work. But in our recent study, we found something unexpected—some proteins can still affect cell behaviour even when they’re turned off. PAK proteins regulate...


Read more at: Professor Ming Du delivers annual Doniach Lecture

Professor Ming Du delivers annual Doniach Lecture

30 June 2025

Celebrating Professor Ming Du’s 2025 Doniach Lecture Last week, pathologists across the UK and Ireland gathered for the annual Doniach Lecture , one of the Pathological Society of Great Britain & Ireland’s flagship events. This year, we were honoured to welcome Professor Ming‑Qing Du as the distinguished recipient and...


Read more at: Balancing Breakthroughs and Bedtime: Adrian Liston on Science, Parenthood, and Equality

Balancing Breakthroughs and Bedtime: Adrian Liston on Science, Parenthood, and Equality

26 June 2025

When people imagine the life of a cutting-edge scientist, they might picture lab coats, late-night research, and groundbreaking discoveries. What they often don’t see is a toddler tugging at a parent’s sleeve or the careful calculus of who picks up the child from daycare. For Professor Adrian Liston, an immunologist at the...


Read more at: Congratulations on our success in the Academic Career Pathways Scheme

Congratulations on our success in the Academic Career Pathways Scheme

13 June 2025

We are thrilled to congratulate the following colleagues on their successful promotions under the University’s Academic Career Pathways (ACP) framework: Clinical Professorship Dr Catherine Elizabeth Hook , HO Promoted to Clinical Professor in recognition of her excellence in clinical/scientific work and honorary consultant...


Read more at: PaCIFiC Facility launch marks a milestone in Cryo-Imaging at Cambridge

PaCIFiC Facility launch marks a milestone in Cryo-Imaging at Cambridge

28 May 2025

The Department of Pathology recently celebrated the successful launch of the Pathogen Cryo-Imaging Facility (PaCIFiC) , drawing over 40 attendees from across the University. Researchers from Biochemistry, Genetics, and Pharmacology joined to explore the facility’s state-of-the-art capabilities in cryo-confocal imaging...


Read more at: Beauty clinics in UK offering banned treatments derived from human cells

Beauty clinics in UK offering banned treatments derived from human cells

31 March 2025

Experts warn of serious health risks of using exosome products that are harvested from human donors. Banned biological products harvested from human cells are being used in UK beauty clinics, according to experts who warn that the luxury treatments could carry serious health risks. Exosomes have been touted as the latest “...


Read more at: AI Technology Offers Breakthrough in Coeliac Disease Diagnosis

AI Technology Offers Breakthrough in Coeliac Disease Diagnosis

25 March 2025

A pioneering artificial intelligence (AI) tool developed in Cambridge has demonstrated its potential to revolutionize the diagnosis of coeliac disease, significantly accelerating the process and alleviating pressure on healthcare systems. The groundbreaking study, published in the New England Journal of Medicine, showcases...


Read more at: Groundbreaking Review Unveils New Molecular Insights into Extranodal Marginal Zone Lymphoma

Groundbreaking Review Unveils New Molecular Insights into Extranodal Marginal Zone Lymphoma

10 March 2025

Professor Ming-Qing Du from the University of Cambridge conducted a pivotal review of the pathogenesis of extranodal marginal zone lymphoma (EMZL). This study, published in Blood , sheds new light on the molecular mechanisms underlying EMZL and provides a framework for future research. EMZL, a type of B-cell lymphoma...